[HTML][HTML] COVID-19: a new challenge for pulmonary rehabilitation?
M Kołodziej, J Wyszyńska… - Journal of Clinical …, 2021 - mdpi.com
Coronavirus disease 2019 (COVID-19), currently one of the immense burdens for global
healthcare, is often characterized by rapid progression and the occurrence of symptoms …
healthcare, is often characterized by rapid progression and the occurrence of symptoms …
[HTML][HTML] Physiotherapy management for COVID-19 in the acute hospital setting and beyond: an update to clinical practice recommendations
This document provides an update to the recommendations for physiotherapy management
for adults with coronavirus disease 2019 (COVID-19) in the acute hospital setting. It …
for adults with coronavirus disease 2019 (COVID-19) in the acute hospital setting. It …
Influence of SARS-CoV-2 on airway mucus production: A review and proposed model
DK Meyerholz, LR Reznikov - Veterinary pathology, 2022 - journals.sagepub.com
Coronavirus disease 2019 (COVID-19) is a worldwide pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) that has affected millions of lives …
respiratory syndrome coronavirus 2 (SARS-CoV-2) that has affected millions of lives …
Mucus targeting as a plausible approach to improve lung function in COVID-19 patients
Abstract COVID-19 (SARS-CoV-2) has emerged as one of the worst pandemics that have
tormented the globe due to its highly contagious nature. Even if the disease manifests fever …
tormented the globe due to its highly contagious nature. Even if the disease manifests fever …
[HTML][HTML] Associations of symptom combinations with in-hospital mortality of coronavirus disease-2019 patients using South Korean National data
Background There are various risk factors for death in coronavirus disease-2019 (COVID-
19) patients. The effects of symptoms on death have been investigated, but symptoms were …
19) patients. The effects of symptoms on death have been investigated, but symptoms were …
COVID‐19 end‐of‐life care: symptoms and supportive therapy use in an Australian hospital
AK Wong, L Demediuk, JY Tay, O Wawryk… - Internal Medicine …, 2021 - Wiley Online Library
Background Descriptions of symptoms and medication use at end of life in COVID‐19 are
limited to small cross‐sectional studies, with no Australian longitudinal data. Aims To …
limited to small cross‐sectional studies, with no Australian longitudinal data. Aims To …
[PDF][PDF] Toward an optimized strategy of using various airway mucus clearance techniques to treat critically ill COVID-19 patients
M Luo, K Ni, Y Sun, J Guo, K Wen, L Deng - Biocell, 2022 - academia.edu
Toward an optimized strategy of using various airway mucus clearance techniques to treat
critically ill COVID-19 patients Page 1 Toward an optimized strategy of using various airway …
critically ill COVID-19 patients Page 1 Toward an optimized strategy of using various airway …
[HTML][HTML] Effect of nebulized bromac on rheology of artificial sputum: relevance to muco-obstructive respiratory diseases
K Pillai, AH Mekkawy, J Akhter, DL Morris - Advances in Respiratory …, 2023 - mdpi.com
Highlights What are the main findings? BromAc is a better mucolytic compared to bromelain
or N-acetylcysteine alone. BromAc reduces the viscosity and increases the flow rate of …
or N-acetylcysteine alone. BromAc reduces the viscosity and increases the flow rate of …
[HTML][HTML] Nursing Practice of Airway Care Interventions and Prone Positioning in ICU Patients with COVID-19—A Dutch National Survey
AA Esmeijer, F van der Ven, E Koornstra… - Journal of clinical …, 2024 - mdpi.com
Background: Airway care interventions and prone positioning are used in critically ill patients
with coronavirus disease 2019 (COVID-19) admitted to the intensive care unit (ICU) to …
with coronavirus disease 2019 (COVID-19) admitted to the intensive care unit (ICU) to …
[HTML][HTML] One stone two birds: anti-inflammatory bronchodilators as a potential pharmacological strategy for COVID-19
Y Yu, B Fang, XD Yang, Y Zheng - Frontiers in Pharmacology, 2023 - frontiersin.org
The ongoing Coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has imposed a huge threat to public …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has imposed a huge threat to public …